Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Go and pass 0,42 after it will be easier

<< Previous

Bullboard Posts

Next >>

Comment by moneynorthboundon Dec 11, 2020 12:46pm

55 Views

Post# 32089055

RE:Go and pass 0,42 after it will be easier

sylvain_007 wrote: We just hope that the price of this share will go up for the rest of the P.M. it's will be a nice gift for all. Do not forget the good news to come with the webinar on december 15.s

I repeat I am happy anywhere @41 above. Its a solid strong hold ready for Monday opening bell! But rumours on the other bb's say we are gunna close @45

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide